An insulin-responsive element (IRE) in the rat angiotensinogen (ANG) gene promoter that binds to two nuclear proteins with apparent molecular weights of 48 and 70 kD was identified previously from rat immortalized renal proximal tubular cells (IRPTC). The present studies aimed to identify and clone the 48-kD nuclear protein and to define its action on ANG gene expression. Nuclear proteins were isolated from IRPTC and subjected to two-dimensional electrophoresis. The 48-kD nuclear protein was detected by Southwestern blotting and subsequently identified by mass spectrometry, revealing that it was identical to 46-kD heterogeneous nuclear ribonucleoprotein F (hnRNP F), a nuclear protein that binds to TATA-binding protein and associates with RNA polymerase II and also interacts with nuclear cap-binding complex. The hnRNP F cDNA was cloned from IRPTC by reverse transcriptase-PCR. Bacterially expressed recombinant hnRNP F bound to the rat ANG-IRE, as revealed by gel mobility shift assay. The addition of polyclonal antibodies against hnRNP F yielded a supershift in gel mobility. Transient transfer of sense and antisense hnRNP F cDNA in IRPTC inhibited and enhanced ANG gene expression, respectively. High glucose stimulated and insulin inhibited hnRNP F expression in IRPTC. Expression studies indicated that hnRNP F is present in the kidney, testis, liver, lung, and brain but not in the spleen. In conclusion, these studies demonstrate that hnRNP F binds to rANG-IRE and modulates renal ANG gene expression, implicating that dysregulation of hnRNP F might affect renin-angiotensin system activation and, subsequently, kidney injury in diabetes.
I
nsulin regulates the expression of Ͼ100 genes by affecting the transcription, mRNA stability, or mRNA translation (1, 2) . The underlying mechanisms of insulin regulation of gene transcription and mRNA stability are poorly understood. One major obstacle that is hampering the progress at the transcriptional level is that there is no consensus insulin response element (IRE) that can account for the regulation of all insulinresponsive genes. This is in contrast with consensus-responsive elements that have been described for other hormones, e.g., the steroid hormone receptors. However, some genes whose transcription is inhibited by insulin seem to share a common IRE (T[G/A]TTT[T/G][G/T]) core sequence, including phosphoenolpyruvate carboxykinase, IGF-binding protein-1, tyrosine aminotransferase, glucose-6-phosphatase, apolipoprotein C III, and aspartate aminotransferase (3) (4) (5) (6) (7) (8) . Transacting factors that interact with the above common IRE have been tentatively identified, but none has been shown directly to mediate an insulin response. Moreover, other genes contain a well-defined IRE, but its sequence is substantially different from the common IRE (2); thus, it has been postulated that no single common transacting factor could be associated with all IRE of different genes.
Angiotensinogen (ANG) is a glycoprotein that consists of 452 amino acid residues with an apparent molecular weight of 62 to 65 kD (9, 10) . ANG is principally expressed in the liver and is the sole substrate in the renin-angiotensin system (RAS). In addition to the well-characterized systemic RAS, the presence of a local intrarenal RAS has now been generally accepted (11, 12) . The mRNA and protein for all RAS components, including ANG, renin, angiotensin-converting enzyme (ACE), and angiotensin II (Ang II) receptors (AT 1 R and AT 2 R subtypes), are expressed in murine and rat immortalized renal proximal tubular cells (IRPTC) (13) (14) (15) (16) (17) (18) (19) (20) . Several studies have reported that Ang II levels, ANG, and renin mRNA expression are elevated in early diabetic kidney (16, 21, 22) , suggesting that hyperglycemia and/or augmented intrarenal Ang II may be directly or indirectly responsible for renal proximal tubular hypertrophy and tubulointerstitial fibrosis in diabetes.
In previous studies, we showed that high glucose stimulates and insulin inhibits ANG gene expression and cell hypertrophy in IRPTC (23) (24) (25) (26) (27) (28) (29) (30) (31) . Moreover, we identified a putative IRE motif . Rabbit polyclonal antiserum raised against the full-length human hnRNP F and antiserum predominantly recognizing hnRNP F (CTARRYIGIVKQAGLER corresponding to amino acids 215 to 230 of human hnRNP F [33] ) were a gift from Dr. Taka-aki Tamura (Chiba University, Chiba, Japan) and Dr. Christine Milcarek (University of Pittsburgh School of Medicine, Pittsburgh, PA), respectively. The characteristics of these antisera have been reported (34, 35) . The bacterial expression vector pGex 4T-3 and mammalian expression vector pcDNA 3.1 were purchased from Amersham-Pharmacia Biotech and InVitrogen (Burlington, ON, Canada), respectively. Restriction modified enzymes were acquired from InVitrogen., Amersham-Pharmacia Biotech, or Roche Diagnostics (Laval, QC, Canada). Oligonucleotides for rat ANG-IRE N-882 to N-855 (5Ј-CCT CCC TTC  CCG CCC TTC ACT TTC TAG T-3Ј) (32), mutants of ANG N-882 to  N-885 (M1, 5Ј-CCT CCC TTC CAT TAC TTC ACT TTC TAG T-3Ј; M2,  5Ј-CCT CCC TTA AAT AAG ACC ACT TTC TAG T-3Ј; M3, 5Ј-CCT CCC  TTC CCT TCC TTC ACT TTC TAG T-3Ј; M4, 5Ј-CCT CCC TTC CCT  CCC TTC ACT TTC TAG T-3Ј), rANG-IRE motif N-878 to N-864  (5Ј-CCT TCC CGC CCT TCA-3Ј), concatameric rANG-IRE motif (3 X  N-878 to N-864, 5Ј-CCT TCC CGC CCT TCA CCT TCC CGC CCT TCA  CCT TCC CGC CCT TCA-3Ј), IRE of human glyceraldehyde-3-phosphate dehydrogenase gene (hGAPDH-IRE; N-473 to N-477, 5Ј-CCA  ACT TTC CCG CCT CTC AGC CTT TGA A-3Ј) (36) , and IRE of rat glucagon gene (N-267 to N-242, 5Ј-AGT TTT CAC GCC TGA CTG AGA TTG A-3Ј) (37) were synthesized by InVitrogen. The oligonucleotide that contains the consensus SP1-binding site (5Ј-TCG CCC CGC CCC CGA TCG AAT-3Ј) (38) was purchased from Promega (Fisher-Scientific, Montreal, QC, Canada).
The plasmid that contains the concatameric rANG-IRE motif DNA was constructed by inserting the double-stranded concatameric rANG-IRE motif oligonucleotide with the Not-1 enzyme restriction site added on both termini into the polyclonal site of pcDNA 3.1 by conventional method. The double-stranded concatameric rANG-IRE motif DNA fragment then was incised from the plasmid and used for labeling as probe.
The expression vectors and plasmid that contains the coding sequence for chloramphenicol acetyltransferase (CAT) without the promoter (pOCAT) or with Rous sarcoma virus enhancer/promoter sequence (pRSV/CAT) fused to the 5Ј end of the CAT coding sequence, respectively, were a gift from Dr. Joel F. Habener (Massachusetts General Hospital, Boston, MA). Thin-layer chromatography plates were purchased from Fisher Scientific (Montreal, QU, Canada).
Cell Culture
IRPTC at passages 12 to 16 were used in the present studies. The characteristics of IRPTC, which express the mRNA and protein of ANG, renin, ACE, and Ang II receptors, have been described previously (39) .
Cellular and Tissue Nuclear Extract Preparation
Nuclear extracts from 10 plates (150 ϫ 20 mm) each of confluent IRPTC that were previously incubated in DMEM with 5 mM glucose and 20 mM d-mannitol, 25 mM glucose, or 25 mM glucose plus insulin (10 Ϫ7 M) for 24 h and rat tissues (liver, kidney, testis, lung, brain, and spleen) were prepared according to the method of Henninghausen and Lubon (40) with slight modifications, as we have described elsewhere (31, 41) .
2-D Electrophoresis
2-D electrophoresis was carried out with the IPGphor Isoelectric Focusing Unit (Amersham-Pharmacia Biotech). For isoelectrofocusing (IEF), precast 13-cm IPG strips (pH 3 to 10, nonlinear, Immobiline DryStrips; Amersham-Pharmacia Biotech) were pre-equilibrated with 750 g of nuclear extracts in 250 l of rehydration buffer (8 M urea, 1 M thiourea, 4% CHAPS, 2% IPG buffer, 1% NP-40, 0.1 M dithiothreitol (DTT), and 0.0001% of bromophenol blue [BPB]) for Ͼ12 h according to the supplier's manual. IEF was run for 90 kV-hours at 25°C. After IEF separation, the IPG strips were immediately equilibrated for 15 min with a buffer that contained 50 mM Tris-HCl (pH 6.8), 6 M urea, 30% glycerol, 2% SDS, 2% DTT, and 0.0001% of BPB. Then, the strips were re-equilibrated with another buffer that contained 50 mM Tris-HCl (pH 6.8), 6 M urea, 30% glycerol, 2% SDS, 2% iodoacetamide, and 0.0001% BPB for an additional 15 min. For 2-D separation, the IPG strips were placed above 10% PAGE that contained SDS and electrophoresed. Amersham's rainbow markers served as molecular weight markers. IRPTC nuclear extracts (100 g) were run on the same 10% PAGE-SDS as controls. Each sample was divided into two strips for 2-D electrophoresis. One gel was stained with Coomassie Brilliant Blue R-250 (Amresco, Solon, OH) to visualize proteins. The other was electrotransferred to a Hybond C-extra membrane (Amersham-Pharmacia Biotech) for Southwestern blotting.
Southwestern Blotting
Southwestern blotting was performed according to the procedure of Kwast-Welfeld et al. (42) with slight modifications (31, 41) . Briefly, IRPTC nuclear proteins (200 g) were resolved on a 4 to 20% PAGE-SDS gradient or on 10% PAGE-SDS (43) , then electrotransferred to a Hybond C-extra membrane, which was incubated with 10% (wt/vol) nonfat milk proteins in a binding buffer that contained 10 mM HEPES (pH 7.0), 10 mM MgCl 2 , 50 mM NaCl, 0.25 mM EDTA, and 2.5% glycerol (vol/vol) for 24 h at 4°C. The membrane was washed at least twice with binding buffer that contained 0.25% nonfat milk proteins. Subsequently, it was hybridized overnight with 32 P-labeled concatameric ANG-IRE motif DNA (approximately 1.0 to 2.0 pmol; 10 cp/ml) in binding buffer that contained 0.25% nonfat milk proteins and 300 g/ml nondenatured herring sperm DNA at 4°C. The membrane was finally washed, air-dried, and exposed for autoradiography.
Matrix-Assisted Laser Desorption/Ionization Mass Spectroscopy
Spots on the gel corresponding to positive signals of the Southwestern blot membrane were picked up for matrix-assisted laser desorption/ionization mass spectroscopy (MALDI-MS). All MALDI-MS analyses were performed at the Quebec Genome Centre (McGill University, Montreal, QC, Canada). Briefly, protein samples first were cleaved by trypsin and then subjected to MALDI-MS. MALDI-MS analysis was conducted at 20 kV accelerating voltage and 23 kV reflecting voltage. For protein identification, peptide mass fingerprints were searched by the Mascot program developed by Matrix Science Ltd. (freely accessible at www.matrixscience.com).
Cloning of hnRNP F
hnRNP F was cloned from IRPTC by conventional reverse transcription-PCR. Sense and antisense primers corresponding to nucleotides N ϩ 1 to N ϩ 19 (5Ј-ATG ATG CTG GGC CCT GAG G-3Ј) and N ϩ 1228 to N ϩ 1245 (5Ј-TCG TAC CCA CCT ATA CTA ATC-3Ј) of rat hnRNP F cDNA (35) were used in PCR. In addition, the Not 1 enzyme restriction site was added on the 5Ј and 3Ј ends of sense and antisense primers, respectively. hnRNP F cDNA then was subcloned in sense and antisense orientation at the polyclonal site (Not 1) of the bacterial expression vector pGex 4T-3 or mammalian expression vector pcDNA 3.1 by conventional method.
Purification of Recombinant hnRNP F from Bacteria
Escherichia coli BL-21 cells (Amersham-Pharmacia Biotech) were transformed by pGex 4T-3 that contained rat hnRNP F cDNA. Expression of the fusion protein (GST fused with hnRNP F [GST-hnRNP F]) in BL-21 cells was induced by the addition of 0.5 mM isopropylthiogalactoside into the culture medium with incubation for 4 h. The bacteria then were harvested, and GST-hnRNP F fusion proteins were purified from the bacterial extracts by GST affinity column chromatography according to the manufacturer's protocol (Amersham-Pharmacia Biotech). The purified GST-hnRNP F fusion proteins were used in gel mobility shift assays (GMSA).
GMSA
GMSA were performed according to method described elsewhere (31, 41) , using the labeled monomeric ANG-IRE motif DNA as probe. Briefly, the rANG-IRE DNA fragment was 5Ј end labeled with [␥-32 P]ATP by T 4 polynucleotide kinase. Purified GST-hnRNP F fusion proteins (1 g) or GST (5 g) or IRPTC nuclear proteins (5 g) in the presence of 0.3 units of poly(dI/dC) in 20 mM HEPES (pH 7.6), 1 mM EDTA, 50 mM KCl, 2 mM spermidine, 1 mM DTT, 0.5 mM PMSF, and 10% glycerol (vol/vol) were incubated for 30 min at room temperature. Then, the 5Ј-labeled probe (approximately 0.1 pmol) was added and incubated further for 30 min at room temperature. After being chilled on ice, the mixture was run on 5% (wt/vol) nondenaturing PAGE and exposed for autoradiography. In competition assays, 100-to 300-fold molar excess of unlabeled DNA fragments was added to the reaction mixture and incubated for 30 min at room temperature before incubation with the labeled probe. In supershift assays, 0.5 to 2 l of polyclonal antibodies against hnRNP F was added in the reaction mixture and incubated for 30 min on ice before incubation with the labeled probe.
Mammalian Expression of Recombinant hnRNP F
Mammalian expression vector pcDNA 3.1 that contained rat hnRNP 
Western Blotting for hnRNP F
Briefly, the cellular proteins and nuclear extracts were dissolved in 700 l of lysis buffer (62.5 mM Tris-HCl [pH 6.8] that contained 2% [wt/vol] SDS, 10% glycerol, 50 mM DTT, 1 mM PMSF, 1 g/ml leupeptin, 1 g/ml aprotinin, and 0.1% [wt/vol] BPB), sonicated for 15 s, heated at 95°C for 5 min, and centrifuged at 12,000 ϫ g for 5 min. Thirty-five microliters of the supernatants was subjected to 10% PAGE-SDS gel and then transferred onto a polyvinylidene difluoride membrane (Hybond-P; Amersham-Pharmacia Biotech). The membrane was initially blotted for anti-hnRNP F antibody (1:30,000 dilution) and then reblotted for anti-␤-actin antibody (1:10,000 dilutions) using chemiluminescent developing reagent (Roche Diagnostics). The relative densities of the hnRNP F and ␤-actin bands were quantified by computerized laser densitometry (ImageQuant software, version 5.1; Molecular Dynamics, Amersham-Pharmacia Biotech).
RT-PCR for Quantification of ANG mRNA in IRPTC
Total RNA, isolated with TRIzol reagent (InVitrogen) according to the supplier's protocol and quantified by its absorbance at 260 nm, was deployed in RT-PCR to quantify the amount of ANG mRNA expressed in IRPTC as described previously (25, 26) . The sense and antisense rat ANG primers were 5Ј-CCT CGC TCT CTG GAC TTA TC-3Ј and 5Ј-CAG ACA CTG AGG TGC TGT TG-3Ј, corresponding to N ϩ 729 to N ϩ 748 of exon 2 and N ϩ 111 to N ϩ 130 of exon 3 of rANG gene (9), respectively. The sense and antisense rat ␤-actin primers were 5Ј-ATG CCA TCC TGC GTC TGG ACC TGG C-3Ј and 5Ј-AGC ATT TGC GGT GCA CGA TGG AGG G-3Ј, corresponding to the nucleotide sequences of ϩ155 to ϩ179 of exon 3 and nucleotide sequences of ϩ115 to ϩ139 of exon 5 of the rat ␤-actin gene (44), respectively.
For identifying rANG and ␤-actin cDNA fragments, 10 l of the PCR product were electrophoresed on 1.2% agarose gels and transferred onto a Hybond XL nylon membrane (Amersham-Pharmacia Biotech). Digoxigenin-labeled oligonucleotide 5Ј-GAG GGG GTC AGC ACG GAC AGC ACC-3Ј, corresponding to nucleotide ϩ775 to ϩ798 of rANG cDNA (9) (i.e., nucleotide ϩ828 to ϩ851 of exon 2 of rANG gene [44] ), prepared with a digoxigenin oligonucleotide 3Ј end labeling kit (Roche Diagnostics), was used to hybridize the PCR products on the membrane. After stringent washing, the membrane was detected with a digoxigenin luminescence kit (Roche Diagnostics) and exposed to Kodak BMR film (Eastman Kodak Co., Rochester, NY). After rANG mRNA analysis, the same membrane was stripped and rehybridized with a ␤-actin oligonucleotide probe (sequence: 5Ј-TCC TGT GGC ATC CAT GAA ACT ACA TTC-3Ј, corresponding to nucleotides ϩ9 to ϩ35 of exon 4 of the rat ␤-actin gene [44] ). ANG mRNA levels were normalized by corresponding ␤-actin mRNA levels.
CAT Assay
The method of construction of the rANG-CAT fusion gene pOCAT/ rANG N-1498/ϩ18 and mutant pOCAT/rANG N-1498/ϩ18 with mutated IRE has been described previously (31, 32) . Control plasmid or ANG-CAT fusion gene were transfected into IRPTC using lipofectamine (InVitrogen). We optimized the DNA concentration for gene transfection at 2 to 3 g per 0.5 to 1 ϫ 10 6 cells. Thus, in the present studies, a total of 2 g of supercoiled DNA (i.e., 2 g of pRSV/CAT, 1 g of pOCAT/rANG N-1498/ϩ18, or mutant pOCAT/rANG N-1498/ϩ18 plus 1 g of pcDNA 3.1 or pcDNA 3.1/hnRNP F) was used routinely in cell transfection. Twenty-four hours after the transfection, the media were replaced with fresh 5 mM d-glucose DMEM and incubated for another 24 h. The cells then were harvested and assayed for CAT activity (30) . For normalizing the efficiency of transfection, 0.5 g of pTK/hGH (a vector with thymidine kinase enhancer/promoter fused to 5Ј human growth hormone gene) was co-transfected with pRSV/CAT or pOCAT/rANG N-1498/ϩ18 as described previously (30) . The plasmid pRSV/CAT served as a positive control to monitor the efficiency of transfection of rANG-CAT fusion gene. The level of transfection efficiency for pRSV/CAT in IRPTC ranged from 60 to 90%, i.e., the percentage of conversion of 14 C chloramphenicol to mono-and diacetyl chloramphenicol. The transfection efficiency of pOCAT/rANG N-1498/ϩ18 in IRPTC ranged from 25 to 35% compared with pRSV-CAT. The inter-and intra-assay coefficients of variation of transfection for pOCAT/rANG N-1498/ϩ18 in IRPTC are 25 and 12% (n ϭ 10), respectively. The method for CAT assay has been described previously (30) .
Statistical Analyses
Three to five separate independent experiments were performed per protocol, and each treatment group was run in duplicate. The data were analyzed by one-way ANOVA and the Bonferroni test. P Յ 0.05 was regarded as statistically significant. Figure 1A shows the staining of nuclear proteins after 2-D electrophoresis. Southwestern blotting of IRE-BP after 2-D electrophoresis is displayed in Figure 1B . It is apparent that two positive spots with an apparent molecular weight of 46 to 48 kD were identified, and these spots were cut out and subjected to MALDI-MS. The MS results are displayed in Figure 2 . The two spots identified a common protein designated as RIKEN (Accession no. 4833420I20 [Mus musculus]). Database analysis revealed that RIKEN is identical to the rat hnRNP F cDNA sequence reported by Yoshida et al. (34) .
Results

Identification of Rat IRE-BP in IRPTC
To confirm the authenticity of rat hnRNP F revealed by Southwestern blotting, we stripped the radioactivity from the membrane and reblotted with rabbit polyclonal antiserum against hnRNP F, as shown in Figure 1C . It is apparent that the proteins that interact with anti-hnRNP F were superimposable with positive signals detected by Southwestern blotting, as seen in Figure 1B . These data confirm that the proteins that interact with rat ANG-IRE are identical to hnRNP F.
GMSA
Bacterially expressed recombinant hnRNP F was used to study the interaction of putative rANG-IRE (N-878 to N-864) with hnRNP F. Figure 3 illustrates the analysis of GST-hnRNP F fusion proteins by 10% PAGE-SDS gel. Three major bands with apparent molecular weights of 26, 44, and 69 to 72 kD were induced by isopropylthiogalactosidase ( Figure 3A) . The 44-and 69-to 72-kD species interacted with rabbit antiserum against hnRNP F but not the 26-kD species ( Figure 3B ). The 26-kD molecular species was the induced GST protein, according to information provided by the supplier (Amersham-Pharmacia Biotech). The 69-to 72-kD molecular species had the molecular weight of hnRNP F (46 kD) fused with GST (26 kD), whereas the 44-kD molecular species was likely partially degraded GST-hnRNP F fusion proteins. Partially purified GSThnRNP F (Figure 3, lane 7) was used in subsequent GMSA.
When the labeled rANG-IRE DNA was incubated with GSThnRNP F, one major band that consisted of two species appeared with retarded mobility ( Figure 4A ). No slowly migrating band was observed when the labeled DNA was incubated with GST (bacterial extract of empty vector pGex 4T-3). The addition of an unlabeled rANG-IRE was effective in competing with the binding of labeled rANG-IRE DNA to the fusion proteins(s) (100-and 300-fold molar excess of unlabeled DNA fragment) but not the unlabeled DNA fragment of hGAPDH-IRE, rat glucagon-IRE, and the SP1 consensus sequence ( Figure  4B ). Unlabeled mutants (M3 and M4) of rANG-IRE (N-878 to N-864) were effective in competing with the binding of labeled rANG-IRE DNA but not the unlabeled mutants (M1 and M2) of rANG N-882 to N-855 in competing with the binding of labeled rANG-IRE DNA ( Figure 5 ). These studies showed that the mutation of four nucleotides in N-878 to N-864 was sufficient to abolish binding with hnRNP F, indicating that the rANG N-874 to N-867 sequence localized within nucleotides N-878 to N-864 is important for binding to hnRNP F.
The addition of rabbit antiserum against hnRNP F induced a supershift of rANG-IRE binding with GST-hnRNP F fusion protein in a dose-dependent manner ( Figure 6 ). These data further confirm that rat ANG-IRE binds to hnRNP F. Figure 7 reveals that the labeled rANG-IRE binds three major IRPTC nuclear proteins (labeled bands A, B, and C). Nuclear proteins in all three bands are completely displaced by 100-fold excess of unlabeled rANG-IRE. The addition of rabbit anti-hnRNP F induced a supershift of rANG-IRE binding with nuclear proteins in band A but not in bands B and C. No supershift bands were observed with rabbit nonimmune IgG. These results demonstrate that rANG-IRE binds to endogenous nuclear hnRNP F in IRPTC as well as with two unidentified nuclear proteins.
Effect of hnRNP F on ANG mRNA Expression in IRPTC
HnRNP F expression ( Figure 8A ) from IRPTC that were transiently transfected with pcDNA 3.1/hnRNP F (ϩ) was sig- Figure 6 . Supershift GMSA of the radioactively labeled rANG-IRE DNA fragment with GST-hnRNP F fusion protein(s). The labeled DNA probe (0.1 pmol) was incubated with GST (5 g) or GST-hnRNP F fusion protein(s) (1 g each, lanes 3 to 9) in the presence of 0.3 units of poly dI-dC. Rabbit anti-hnRNP F antiserum (0.5 to 2 l, lanes 4 to 6) or rabbit IgG (0.5 to 2 g, lanes 7 and 9) was added to the reaction mixture and incubated for 30 min on ice before incubation with the labeled probe. Similar observations were made from two other experiments. Figure 7 . Supershift GMSA of the radioactively labeled rANG-IRE with IRPTC nuclear protein(s). The labeled DNA probe (0.1 pmol) was incubated with BSA (5 g) or IRPTC nuclear protein(s) (5 g each, lanes 2 to 7) in the presence of 0.3 units of poly dI-dC. Excessive rat ANG-IRE (100-fold) was added for competition with the labeled probe (lane 3). Rabbit IgG (10 and 5 g, lanes 4 and 5, respectively) or rabbit anti-hnRNP F antiserum (1.0 and 0.5 l, lanes 6 and 7, respectively) was added the reaction mixture and incubated for 30 min on ice before incubation with the labeled probe. Similar observations were made from two other experiments. SS, supershift band. nificantly higher (P Ͻ 0.05) than in IRPTC that were transiently transfected with empty vector pcDNA 3.1 or pcDNA 3.1/ hnRNP F (Ϫ), as analyzed by Western blotting. It is apparent, however, that basal ANG mRNA levels in IRPTC that were transiently transfected with pcDNA 3.1/hnRNP F (ϩ) were significantly lower (50% decrease; P Ͻ 0.05) than those in nontransfected IRPTC ( Figure 8B ). In contrast, ANG mRNA levels were significantly higher (200% increase; P Ͻ 0.01) in IRPTC that were transiently transfected with pcDNA 3.1/ hnRNF (Ϫ) than those in nontransfected IRPTC ( Figure 8B ). These results demonstrate that transfected sense and antisense hnRNP F cDNA, respectively, suppressed and enhanced the expression of endogenous ANG mRNA in IRPTC. Figure 9 indicates that co-transfection with hnRNP F significantly suppresses rANG gene promoter activity. However, co-transfection with hnRNP F had no inhibitory effect on mutant rANG gene promoter activity. These studies support the notion that hnRNP F modulates ANG gene expression at the transcriptional level via binding to the IRE. Figure 10A shows the Southwestern blot analysis of hnRNP F expression in IRPTC nuclear extract by using the labeled rANG-IRE. After Southwestern blot analysis, the same membrane was blotted with the polyclonal antibodies against the hnRNP F ( Figure 10B ). Southwestern blotting analysis reveals that high glucose levels (25 mM) enhanced and insulin suppressed the expression of 48-and 70-kD molecular species from IRPTC. The polyclonal antibodies against the hnRNP F interacted with a predominant molecular species of 48 kD and a minor species of 46 kD. The 48-kD molecular species detected by Southwestern blotting ( Figure 10A ) is superimposed or corresponds to the 48-kD species detected by Western blotting ( Figure 10B ). These data demonstrate that the 70-kD IRE-BP is immunologically different from the hnRNP F. The expression of HnRNP F and unidentified 70-kD IRE-BP is regulated by high glucose and insulin in IRPTC. Figure 11 illustrates the tissue distribution of the hnRNP F protein in various rat tissues by Western blotting. It is apparent that the hnRNP protein is present in the nuclear extracts of kidney, liver, testis, lung, and brain but not in the spleen.
Effect of hnRNP F on rANG Gene Promoter Activity
Effect of High Glucose and Insulin on hnRNP F Expression in IRPTC
Tissue Distribution of hnRNP F in Rat Tissues
Discussion
The present studies used a combination of Southwestern blotting and proteomics and identified hnRNP F as one of the nuclear proteins that bind to IRE of the rat ANG gene promoter and inhibits ANG gene expression in IRPTC. We demonstrated previously that high glucose enhances the expression of both 48-and 70-kD nuclear proteins in IRPTC, and insulin inhibits this increment, suggesting that 48-and 70-kD nuclear proteins may mediate the effect of high glucose and insulin on ANG gene expression in IRPTC. Because the molecular structure of the 48-and 70-kD IRE-BP is unknown, the present studies aimed to identify their molecular structure. It is apparent that multiple IRPTC proteins are resolved by 2-D electrophoresis. A second gel run simultaneously with the first gel for Southwest- ern blotting demonstrated two positive spots with an apparent molecular weight of 46 to 48 kD and pI of 5.0 to 6.0 that closely matched the stained protein spots on the first gel. After tryptic digestion and MALDI-MS, these two spots were found to match the partial amino acid sequence deduced from RIKEN cDNA (Accession no. 4833420I20, gi 19527048 and NM 133834). The cDNA sequence of RIKEN is identical to the hnRNP F sequence as reported by Yoshida et al. (34) (Accession no. BAA 37095). Using specific rabbit antiserum against hnRNP F, we confirmed the identity of hnRNP F on the membrane from Southwestern blot. Western blotting revealed positive signals superimposed on the positions of the two spots detected by Southwestern blotting. The reason that hnRNP F is present in two different forms (same apparent molecular weight but different pI) is presently unclear. One possibility is that these proteins might be variants with different phosphorylated forms.
A broad spot with an apparent molecular weight of 68 to 70 kD (denoted by broken rectangle in Figure 1 ) was detected by Southwestern blotting. Subsequent MALDI-MS analysis of this spot, however, could not yield a definite peptide with a significantly high Masscot score. These data suggest that the positive broad spot detected by Southwestern blotting is a cluster of several different proteins.
To demonstrate that hnRNP F interacts with rANG-IRE, we cloned hnRNP F from IRPTC by conventional RT-PCR and expressed it in a bacterial system for use in GMSA. Our GMSA revealed that labeled rANG-IRE DNA interacted with GSThnRNP F fusion protein(s) but not with GST proteins. The addition of unlabeled rANG-IRE DNA effectively displaced labeled ANG-IRE at or greater than a 100-fold molar excess of unlabeled DNA, whereas unlabeled hGAPDH-IRE, rat glucagon-IRE, SP1 consensus sequence, and mutants M1 and M2 of rANG-IRE were not effective in displacing labeled rANG-IRE. In contrast, M3 and M4 were effective in competing with labeled ANG-IRE. These studies demonstrate that nucleotides N-878 to N-864 represent the rANG-IRE motif, which is essential for binding to hnRNP F fusion proteins.
Most convincing, the addition of specific rabbit polyclonal antibodies against hnRNP F yielded a supershift of labeled rANG-IRE binding with hnRNP F fusion proteins in a dosedependent manner. Moreover, the addition of rabbit polyclonal antibodies against hnRNP F yielded a supershift of labeled rANG-IRE binding with IRPTC nuclear proteins but not with rabbit IgG. Taken together, these data demonstrate unequivocally that hnRNP F binds to rANG-IRE.
There are at least 20 to 30 independent hnRNP species in mammalian cells (45, 46) . Because antibodies against hnRNP Figure 9 . Effect of hnRNP F on rANG gene promoter activity in IRPTC. Forty-eight hours after transfection, cells were harvested and assayed for chloramphenicol acetyltransferase (CAT) activity. The relative activity in cells that were transfected with 1 g of pOCAT/rANG N-1498/ϩ18 or mutant pOCAT/rANG N-1498/ϩ18 was given a relative value of 100% (control). Each point represents the mean Ϯ SD of three independent experiments (*P Յ 0.05; **P Յ 0.01).
affect splicing (47) (48) (49) and hnRNP are associated with poly (A)-containing RNA, i.e., premRNA and mRNA, and found to be constituents of the splicesome (47), they are believed to be important in splicing events. HnRNP F is a member of a subfamily of hnRNP proteins that includes at least F, H, and HЈ proteins (33, 50) . These proteins are highly related; hnRNP H and HЈ are 96% identical and 78 and 75% identical to hnRNP F, respectively (33, 50) . HnRNP F has the unique nucleotide binding property of binding to (G/C)-stretch of double-stranded DNA and RNA sequences via its GY-rich motif and RNAbinding domains, respectively (34) . Studies on hnRNP F and H/HЈ have revealed that these proteins participate at various steps in the processing of cellular mRNA, e.g., in alternating splicing of the c-src gene (51), the ␤-tropomyosin gene (52) , and the thyroid hormone receptor gene (53) . Furthermore, Veraldi et al. (54) demonstrated that differential changes in expression levels of hnRNP F and H/HЈ are involved in controlling the synthesis of membrane-bound versus secreted antibodies during the development of memory B cells into plasma cells. Most interesting, studies by Yoshida et al. (55) and Gamberi et al. (56) demonstrated that hnRNP F could bind to TATA-binding protein, associates with RNA polymerase II, and interacts directly with nuclear cap-binding protein complex, suggesting that hnRNP F could modulate gene expression at the transcriptional and posttranscriptional levels. Thus, these data strongly indicate that the members of this subfamily are important for the control of gene expression at both the transcriptional and the posttranscriptional levels in various cells.
Surprising, overexpression and downexpression of hnRNP F inhibits and augments ANG mRNA expression and ANG gene promoter activity in IRPTC, respectively. To the best of our knowledge, the present report is the first to demonstrate that hnRNP F can modulate ANG gene expression in kidney proximal tubular cells in vitro. At present, the molecular mechanism(s) of hnRNP F action on ANG gene expression is not known. One possibility is that hnRNP F behaves like a negative transacting protein and inhibits the binding of other positive transacting factor(s) (e.g., the p70 kD IRE-BP) to TATA-binding protein and RNA polymerase II, subsequently attenuating ANG gene expression. The second possibility is that hnRNP F overexpression exhausts the availability of nuclear scap-binding protein for capping premRNA, which would subsequently attenuate the formation of mature ANG mRNA in the cytoplasm. The third possibility is that hnRNP F could bind to Ϫ7 M) and 5% FBS for 24 h. Then, cells were harvested and nuclear proteins (100 g) were subjected to Southwestern blotting as described in the Materials and Methods section. (B) Western blot analysis. After Southwestern blot analysis, the same membrane was blotted with rabbit polyclonal antibodies against hnRNP F and ␤-actin control and ECL-chemiluminescent developing reagent. The relative densities of hnRNP F bands were compared with the ␤-actin control. The level of hnRNP F expressed in IRPTC in 5 mM glucose medium was considered to be the control (100%). Each bar represents the mean Ϯ SD of three independent experiments (*P Յ 0.05, **P Յ 0.01).
unidentified splicing silencer(s) in ANG premRNA and subsequently alter the normal splicing of ANG premRNA in the nucleus. Finally, it is possible that hnRNP F is a negative regulatory protein, but its negative effect is normally neutralized by interaction (heterodimerization) with the unidentified 70-kD IRE-BP (a hypothetical positive regulatory transacting factor that binds to rANG-IRE) in cells. HnRNP F overexpression then will exceed the neutralization ability of the unidentified 70-kD IRE-BP and subsequently attenuate ANG mRNA expression. More studies are definitely needed along these lines to elucidate the mechanism(s) of action of hnRNP F on ANG gene expression in IRPTC.
Finally, our studies reveal that high glucose stimulated and insulin inhibited the expression of hnRNP F in IRPTC. To the best of our knowledge, this is the first report that hnRNP F could be modulated by high glucose and insulin in kidney proximal tubular cells in vitro. Our tissue distribution analysis revealed that the hnRNP F protein is detectable in the nuclear extracts of rat liver, kidney, testis, brain, and lung but not in the spleen. Rat liver, kidney, testis (epididymis), brain, and lung are known to express ANG mRNA (57, 58) . These observations raise the possibility that the expression of hnRNP F might have a role in regulating ANG gene expression in these tissues.
In summary, we have identified a nuclear protein that binds to rANG-IRE by a combination of Southwestern blotting and proteomics. This IRE-BP is identified as hnRNP F. hnRNP F modulates ANG gene expression in IRPTC. Finally, it seems that high glucose and insulin regulate hnRNP F expression in IRPTC, and hnRNP F is detected in various rat tissues that express ANG mRNA. The present studies raise the possibility that the expression of hnRNP and the unidentified 70-kD IRE-BP may play an important role in regulating local intrarenal RAS activation. Dysregulation of the expression of hnRNP F and unidentified 70-kD IRE-BP may contribute to renal injury in diabetes via altering local intrarenal RAS activation.
